Global Temperature-controlled Packaging for Pharmaceutical Market Research Report Information by Product, by Type, by Temperature Range, by Payload Capacity, by Use, Medicine Type, by End-use Industry, and by Region

Description

List of Tables

Global Temperature-controlled Packaging for Pharmaceutical Market Research Report Information by Product (Shippers and Containers), by Type (Active System and Passive System), by Temperature Range (-20°C and Below, -20°C to 0°C, 2°C to 8°C, 8°C to 25°C, and Above 25°C), by Payload Capacity (Up to 10 L, 10 L - 20 L, 20 L - 40 L, 40 L - 150 L, and Above 150 L), by Use (Single Use and Reusable), Medicine Type (Temperature Sensitive Pharmaceutical Drugs, Vaccine, and Regenerative Medicine), by End-use Industry (Pharmaceuticals and Clinical Trails), and by Region (North America, Europe, Asia Pacific, and Rest of the World) - Forecast Till 2030

Market Overview

A compound annual growth rate (CAGR) of 9.2% is anticipated for the Global Temperature-controlled Packaging for Pharmaceutical industry during the forecast period.

The Temperature-controlled Packaging for Pharmaceutical Market is being driven by the Pharmaceutical Industry's growth, the adoption of intelligent cold chain technology, and a variety of government initiatives to support the regional pharmaceutical industry.

The expansion of temperature-controlled packaging for the pharmaceutical market has been facilitated by the increasing demand for packaging in the pharmaceutical industry. Temperature-controlled packaging for pharmaceuticals is intended to ensure that sensitive products are maintained at the appropriate temperature. The healthcare industry is the primary application of these packaging solutions for the transportation and storage of temperature-sensitive products in a controlled temperature environment.

Market segment insights

The Temperature-controlled Packaging for Pharmaceutical Market is segmented into Shippers and Containers based on the product.

The market is segmented into Active System and Passive System based on type.

The Pharmaceutical Market's Temperature-controlled Packaging is segmented into the following categories: -20°C and Below, -20°C to 0°C, 2°C to 8°C, 8°C to 25°C, and Above 25°C.

The market is segmented into five categories: Up to 10 L, 10 L - 20 L, 20 L - 40 L, 40 L - 150 L, and Above 150 L, all of which are based on payload capacity.

The Temperature-controlled Packaging for Pharmaceutical Market is categorized as either Single Use or Reusable, depending on its intended use.

The Temperature-controlled Packaging for Pharmaceutical Market is segmented into Temperature Sensitive Pharmaceutical Drugs, Vaccine, and Regenerative Medicine, based on the type of medicine.

The Market is segmented into Pharmaceuticals and Clinical Trials based on the end use industry.

Regional Perspectives

In 2023, North America held the largest market share and is anticipated to experience the highest compound annual growth rate (CAGR) during the forecast period. North America is anticipated to be a highly profitable market during the forecast period as a result of the high disposable income levels, numerous patients, and a variety of lifestyle disorders. A expanding geriatric population, in conjunction with pharmaceutical product safety regulations, may increase regional market demand. Increased international trade and bilateral trade agreements may be advantageous to the market.

Asia Pacific has the second largest market share in the global temperature-controlled packaging for pharmaceuticals. It is expected to increase at a revenue-based CAGR during the forecast period. APAC is considered to be highly profitable due to the increase in infectious diseases and the need for cold chain solutions to preserve vaccines. In order to optimize their financial revenues, the Temperature-controlled Packaging for Pharmaceutical Market's most prominent participants may concentrate on the highly promising Asian countries.

In 2017, the European Union (EU) authorities implemented a series of new criteria for pharmaceutical packaging that were directed at counterfeit pharmaceuticals. It is anticipated that Europe will experience substantial growth during the projection period. EU authorities have implemented anti-counterfeiting technologies, including overt, clandestine, and forensic technology, in pharmaceutical packaging. As a result, pharmaceutical packaging companies in the region are continuing to refine their packaging methods and procedures.

Africa, South America, and the Middle East comprise the Rest of the World. The Middle East & Africa market is anticipated to experience a substantial increase in the coming years due to the increasing per capita disposable income, healthcare awareness, and pharmaceutical and drug consumption.

Major Players

Sonoco Thermosafe, UNITED PARCEL SERVICE AMERICA, INC, kaneka Corporation, DHL International GmbH, Deutsche Bahn AG, Cold Chain Technologies, LLC, EMBALL'ISO, Inmark, LLC, kuehne + nagel inc., and CSafe Globalva-Q-tec AG are among the key companies in the Temperature-controlled Packaging for Pharmaceutical Market.

Product Code: MRFR/PNT/5724-CR

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS

1. EXECUTIVE'S HANDBOOK

1.1. THE TOP PERFORMING SEGMENTS
1.2. KEY TRENDS SUMMARIZED
1.3. PRICING OUTLOOK
1.4. STRATEGIC INSIGHTS
1.5. WHO ARE THE KEY PLAYERS IN THE MARKET?

SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE

2. MARKET INTRODUCTION

2.1. DEFINITION
2.2. REPORT SEGMENTATION & SCOPE
2.3. REGIONAL & COUNTRY LEVEL COVERAGE
2.4. WHY YOU NEED THIS REPORT?

3. RESEARCH METHODOLOGY

3.1. OVERVIEW
3.2. DATA FLOW
- 3.2.1. DATA MINING PROCESS
3.3. PURCHASED DATABASE:
3.4. SECONDARY SOURCES:
- 3.4.1. SECONDARY RESEARCH DATA FLOW:
3.5. PRIMARY RESEARCH:
- 3.5.1. PRIMARY RESEARCH DATA FLOW:
- 3.5.2. PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
- 3.5.3. PRIMARY RESEARCH: REGIONAL COVERAGE
3.6. APPROACHES FOR MARKET SIZE ESTIMATION:
- 3.6.1. REVENUE ANALYSIS APPROACH
3.7. DATA FORECASTING
- 3.7.1. DATA FORECASTING TECHNIQUE
3.8. DATA MODELING
- 3.8.1. MICROECONOMIC FACTOR ANALYSIS:
- 3.8.2. DATA MODELING:
3.9. TEAMS AND ANALYST CONTRIBUTION

SECTION III: QUALITATIVE ANALYSIS

4. MARKET DYNAMICS

4.1. INTRODUCTION
4.2. GROWTH PARAMETERS MAPPED - DRIVERS
- 4.2.1. GROWTH IN THE PHARMACEUTICAL INDUSTRY SUPPLEMENTING SALES TO THE SIGNIFICANT EXTENT
- 4.2.2. ADOPTION OF SMARTER COLD CHAIN TECHNOLOGY
4.3. WHAT ARE THE CHALLENGES FACED BY INDUSTRY PARTICIPANTS?
- 4.3.1. RISE IN RAW MATERIAL COSTS
4.4. OPPORTUNITIES
- 4.4.1. VARIOUS GOVERNMENT INITIATIVES ARE CARRIED OUT BY VARIOUS COUNTRIES TO BOOST THE PHARMACEUTICAL INDUSTRY.
4.5. IMPACT ANALYSIS OF COVID-19
- 4.5.1 ECONOMIC IMPACT
  - 4.5.1.1 IMPACT ON THE PACKAGING INDUSTRY
- 4.5.2 IMPACT ON PRODUCTION
- 4.5.3 IMPACT ON TEMPERATURE-CONTROLLED PACKAGING FOR THE PHARMACEUTICAL INDUSTRY
  - 4.5.3.1 IMPACT ON SUPPLY CHAIN
  - 4.5.3.2 IMPACT ON RAW MATERIALS
  - 4.5.3.3 CASH FLOW CONSTRAINTS
- 4.5.1. IMPACT ON WORLD TRADE

5. MARKET FACTOR ANALYSIS

5.1. SUPPLY/VALUE CHAIN ANALYSIS
- 5.1.1. PARTICIPANTS
- 5.1.2. VALUE PERCOLATION ACROSS THE CHAIN
- 5.1.3. INTEGRATION LEVELS
- 5.1.4. KEY ISSUES ADDRESSED
5.2. PORTER'S FIVE FORCES MODEL
- 5.2.1. BARGAINING POWER OF SUPPLIERS
- 5.2.2. BARGAINING POWER OF BUYERS
- 5.2.3. THREAT OF NEW ENTRANTS
- 5.2.4. THREAT OF SUBSTITUTES
- 5.2.5. INTENSITY OF RIVALRY

SECTION IV: QUANTITATIVE ANALYSIS

6. GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT

6.1. INTRODUCTION
6.2. SHIPPERS
6.3. CONTAINERS

7. GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE

7.1. AUTOMOTIVE
7.2. ACTIVE SYSTEM
7.3. PASSIVE SYSTEM

8. GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE

8.1. INTRODUCTION
8.2. -20°C AND BELOW
8.3. -20°C TO 0°C
8.4. 2°C TO 8°C
8.5. 8°C TO 25°C
8.6. ABOVE 25°C

9. GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY

9.1. INTRODUCTION
9.2. UP TO 10 L
9.3. 10 L - 20 L
9.4. 20 L - 40 L
9.5. 40 L - 150 L
9.6. ABOVE 150 L

10. GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE

10.1. INTRODUCTION
10.2. SINGLE USE
10.3. REUSABLE

11. GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE

11.1. INTRODUCTION
11.2. TEMPERATURE SENSITIVE PHARMACEUTICAL DRUGS
11.3. VACCINE
11.4. REGENERATIVE MEDICINE

12. GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END-USE INDUSTRY

12.1. INTRODUCTION
12.2. PHARMACEUTICALS
12.3. CLINICAL TRAILS

13. GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY REGION

13.1. INTRODUCTION
13.2. NORTH AMERICA
- 13.2.1. U.S.
- 13.2.2. CANADA
13.3. EUROPE
- 13.3.1. GERMANY
- 13.3.2. FRANCE
- 13.3.3. U.K.
- 13.3.4. ITALY
- 13.3.5. SPAIN
- 13.3.6. REST OF EUROPE
13.4. ASIA PACIFIC
- 13.4.1. CHINA
- 13.4.2. JAPAN
- 13.4.3. INDIA
- 13.4.4. SOUTH KOREA
- 13.4.5. TAIWAN
- 13.4.6. PHILIPPINES
- 13.4.7. INDONESIA
- 13.4.8. THAILAND
- 13.4.9. MALAYSIA
- 13.4.10. SINGAPORE
- 13.4.11. HONG KONG
- 13.4.12. AUSTRALIA
- 13.4.13. REST OF ASIA-PACIFIC
13.5. REST OF THE WORLD
- 13.5.1. MIDDLE EAST & AFRICA
- 13.5.2. SOUTH AMERICA

SECTION V: COMPETITIVE ANALYSIS

14. COMPETITIVE LANDSCAPE

14.1. INTRODUCTION
14.2. COMPETITION DASHBOARD
14.3. COMPANY MARKET SHARE ANALYSIS,
14.4. WHO ARE THE MARKET DISRUPTORS & INNOVATORS?
14.5. WHAT STRATEGIES ARE BEING ADOPTED BY MARKET LEADERS?
14.6. THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE MARKET
14.7. COMPETITIVE BENCHMARKING
14.8. PUBLIC PLAYERS STOCK SUMMARY
14.9. COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL
14.10. KEY DEVELOPMENTS & GROWTH STRATEGIES
- 14.10.1. PRODUCT DEVELOPMENTS
- 14.10.2. MERGER & ACQUISITION
- 14.10.3. EXPANSION

15. COMPANY PROFILES

15.1. COLD CHAIN TECHNOLOGIES, LLC
- 15.1.1. COMPANY OVERVIEW
- 15.1.2. FINANCIAL OVERVIEW
- 15.1.3. PRODUCT OFFERED
- 15.1.4. KEY DEVELOPMENTS
- 15.1.5. SWOT ANALYSIS
- 15.1.6. KEY STRATEGIES
15.2. EMBALL'ISO
- 15.2.1. COMPANY OVERVIEW
- 15.2.2. FINANCIAL OVERVIEW
- 15.2.3. PRODUCT OFFERED
- 15.2.4. KEY DEVELOPMENTS
- 15.2.5. SWOT ANALYSIS
- 15.2.6. KEY STRATEGIES
15.3. INMARK, LLC
- 15.3.1. COMPANY OVERVIEW
- 15.3.2. FINANCIAL OVERVIEW
- 15.3.3. PRODUCT OFFERED
- 15.3.4. KEY DEVELOPMENTS
- 15.3.5. SWOT ANALYSIS
- 15.3.6. KEY STRATEGIES
15.4. SONOCO THERMOSAFE
- 15.4.1. COMPANY OVERVIEW
- 15.4.2. FINANCIAL OVERVIEW
- 15.4.3. PRODUCT OFFERED
- 15.4.4. KEY DEVELOPMENTS
- 15.4.5. SWOT ANALYSIS
- 15.4.6. KEY STRATEGIES
15.5. VA-Q-TEC AG
- 15.5.1. COMPANY OVERVIEW
- 15.5.2. FINANCIAL OVERVIEW
- 15.5.3. PRODUCT OFFERED
- 15.5.4. KEY DEVELOPMENTS
- 15.5.5. SWOT ANALYSIS
- 15.5.6. KEY STRATEGIES
15.6. DEUTSCHE BAHN AG
- 15.6.1. COMPANY OVERVIEW
- 15.6.2. FINANCIAL OVERVIEW
- 15.6.3. PRODUCT OFFERED
- 15.6.4. KEY DEVELOPMENTS
- 15.6.5. SWOT ANALYSIS
- 15.6.6. KEY STRATEGIES
15.7. DHL INTERNATIONAL GMBH
- 15.7.1. COMPANY OVERVIEW
- 15.7.2. FINANCIAL OVERVIEW
- 15.7.3. PRODUCT OFFERED
- 15.7.4. KEY DEVELOPMENTS
- 15.7.5. SWOT ANALYSIS
- 15.7.6. KEY STRATEGIES
15.8. KUEHNE + NAGEL INC.
- 15.8.1. COMPANY OVERVIEW
- 15.8.2. FINANCIAL OVERVIEW
- 15.8.3. PRODUCT OFFERED
- 15.8.4. KEY DEVELOPMENTS
- 15.8.5. SWOT ANALYSIS
- 15.8.6. KEY STRATEGIES
15.9. UNITED PARCEL SERVICE OF AMERICA, INC.
- 15.9.1. COMPANY OVERVIEW
- 15.9.2. FINANCIAL OVERVIEW
- 15.9.3. PRODUCT OFFERED
- 15.9.4. KEY DEVELOPMENTS
- 15.9.5. SWOT ANALYSIS
- 15.9.6. KEY STRATEGIES
15.10. KANEKA CORPORATION
- 15.10.1. COMPANY OVERVIEW
- 15.10.2. FINANCIAL OVERVIEW
- 15.10.3. PRODUCT OFFERED
- 15.10.4. KEY DEVELOPMENTS
- 15.10.5. SWOT ANALYSIS
- 15.10.6. KEY STRATEGIES
15.11. CSAFE GLOBAL
- 15.11.1. COMPANY OVERVIEW
- 15.11.2. FINANCIAL OVERVIEW
- 15.11.3. PRODUCT OFFERED
- 15.11.4. KEY DEVELOPMENTS
- 15.11.5. SWOT ANALYSIS
- 15.11.6. KEY STRATEGIES

16. RECOMMENDATIONS & EXPERT INSIGHTS

16.1. WHAT IS THE SHORT-TERM VS LONG-TERM OUTLOOK FOR MARKET?
16.2. WHO ARE THE PLAYERS TO LOOK OUT FOR?
16.3. WHAT WILL THE PRODUCT MIX LOOK IN COMING YEARS?

17. MRFR OFFERINGS & TEAM

17.1. CITATIONS & MEDIA
17.2. OUR REGIONAL REPRESENTATIVES
17.3. RELATED REPORTS
17.4. OUR DOMAIN COVERAGE